Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

被引：2
|
作者：
Hernandez-Rivas, Jose-Angel [1 ,2 ]
Gironella Mesa, Mercedes [3 ,4 ]
机构：
[1] Hosp Univ Infanta Leonor, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Univ Complutense Madrid, Dept Med, Madrid, Spain
[3] Hosp Univ Vail dHebron, Serv Hematol, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
来源：
MEDICINA CLINICA | 2020年 / 154卷 / 08期
关键词：
LENALIDOMIDE PLUS DEXAMETHASONE; TREATMENT STRATEGIES; CONSENSUS; STRATIFICATION; CARFILZOMIB; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I：
10.1016/j.medcli.2019.10.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 319
页数：5
相关论文
共 50 条
  • [1] Strategies to Overcome High-Risk Multiple Myeloma
    Sanchez, Larysa
    CANCER JOURNAL, 2021, 27 (03) : 201 - 204
  • [2] Approach to High-Risk Multiple Myeloma
    Chen, Xiaoyi
    Varma, Gaurav
    Davies, Faith
    Morgan, Gareth
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) : 497 - 510
  • [3] Drug response prediction in high-risk multiple myeloma
    Vangsted, A. J.
    Helm-Petersen, S.
    Cowland, J. B.
    Jensen, P. B.
    Gimsing, P.
    Barlogie, B.
    Knudsen, S.
    GENE, 2018, 644 : 80 - 86
  • [4] High-risk multiple myeloma: how to treat at diagnosis and relapse?
    Mateos, Maria-Victoria
    Martinez, Borja Puertas
    Gonzalez-Calle, Veronica
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2021, (01) : 30 - 36
  • [5] High-risk Multiple Myeloma: Definition and Management
    Joseph, Nisha S.
    Gentili, Silvia
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S80 - S87
  • [6] Defining and treating high-risk multiple myeloma
    Usmani, S. Z.
    Rodriguez-Otero, P.
    Bhutani, M.
    Mateos, M-V
    Miguel, J. S.
    LEUKEMIA, 2015, 29 (11) : 2119 - 2125
  • [7] Myc rearrangement redefines the stratification of high-risk multiple myeloma
    Jin, Xianghong
    Li, Hui
    Zhang, Dingding
    Liu, Shuangjiao
    Song, Yuhang
    Zhang, Fujing
    Li, Ziping
    Zhuang, Junling
    CANCER MEDICINE, 2024, 13 (11):
  • [8] Ultra High-Risk Myeloma
    Avet-Loiseau, Herve
    HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2010, : 489 - 493
  • [9] Cytogenetic and clinical risk factors for assessment of ultra high-risk multiple myeloma
    Zhuang, Junling
    Da, Yi
    Li, Hui
    Han, Bing
    Wan, Xia
    Zhu, Tienan
    Chen, Miao
    Duan, Minghui
    Xu, Ying
    Zhao, Yongqiang
    Shen, Ti
    Wu, Yongji
    Zhou, Daobin
    LEUKEMIA RESEARCH, 2014, 38 (02) : 188 - 193
  • [10] Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy
    Schecter, Jordan
    Lentzsch, Suzanne
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) : 277 - 283
12345